Pharming Group (PHAR) Stock Chart & Stock Price History $10.05 -0.05 (-0.50%) Closing price 03:59 PM EasternExtended Trading$9.94 -0.11 (-1.08%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pharming Group Stock Price Performance The Pharming Group (PHAR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 18.37%, with a year-to-date return of -0.10%. In the past month, the stock has decreased 9.13%, reflecting recent market activity. As of the latest close, Pharming Group traded at $10.32 with a market cap of $707.08 million and volume of 991 shares. Receive PHAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.14%1 Month Performance-9.13%3 Month Performance+17.13%Year-To-Date Performance-0.10%1 Year Performance+18.37% PHAR Stock Chart for Thursday, July, 24, 2025 PHAR Chart by TradingView Pharming Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$10.32$10.05-2.62%$10.28$10.19909 shs$688.53 million07/23/2025$10.04$10.32+2.78%$10.23$9.85991 shs$707.08 million07/22/2025$10.14$10.04-1.02%$10.04$9.801,462 shs$687.91 million07/21/2025$10.27$10.14-1.23%$10.29$9.817,995 shs$694.97 million07/18/2025$10.31$10.27-0.39%$10.34$10.254,037 shs$703.60 million07/17/2025$9.95$10.31+3.62%$10.92$10.1614,278 shs$706.39 million07/16/2025$10.10$9.95-1.49%$10.25$9.99735 shs$681.67 million07/15/2025$10.35$10.10-2.42%$10.42$10.10721 shs$687.11 million07/14/2025$10.05$10.35+2.99%$10.35$10.31618 shs$704.12 million07/11/2025$9.98$10.05+0.75%$10.03$10.031,000 shs$683.71 million Get the Latest News and Ratings for PHAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$10.01$9.98-0.35%$10.49$10.005,740 shs$678.60 million07/09/2025$10.16$10.01-1.48%$10.39$9.991,096 shs$680.98 million07/08/2025$10.47$10.16-2.96%$10.59$10.38747 shs$691.19 million07/07/2025$10.38$10.47+0.87%$9.88$9.88796 shs$712.27 million07/04/2025$10.38$10.38$10.58$10.41344 shs$706.16 million07/03/2025$10.65$10.38-2.54%$10.58$10.41344 shs$706.15 million07/02/2025$10.50$10.65+1.44%$10.69$10.522,238 shs$724.52 million07/01/2025$10.68$10.50-1.66%$10.71$10.71540 shs$714.25 million06/30/2025$10.83$10.68-1.39%$11.10$10.4633,193 shs$726.29 million06/27/2025$10.74$10.83+0.80%$11.49$10.495,739 shs$736.49 million06/26/2025$10.95$10.74-1.92%$11.27$10.414,524 shs$730.64 million06/25/2025$11.06$10.95-0.99%$11.00$10.79803 shs$744.94 million06/24/2025$10.49$11.06+5.48%$11.21$10.741,328 shs$752.41 million06/23/2025$10.60$10.49-1.08%$10.38$10.231,221 shs$713.30 million Related Companies ALVO Stock Chart MIRM Stock Chart CPRX Stock Chart GMTX Stock Chart AMRX Stock Chart NAMS Stock Chart RARE Stock Chart OGN Stock Chart APLS Stock Chart IBRX Stock Chart Receive PHAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHAR) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group N.V. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
